Clinical Updates in Frontline CHL

A

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse Reactions: A Focus on Peripheral Neuropathy

By Anna Sureda 4 Videos
491 views
August 30, 2022
Comments 1
Login to view comments. Click here to Login
23:24

2023 SOHO® Brazil: "How I Sequence New Agents in First and Second Li…

SOHO Brazil 2023

A. Moskowitz

163 views
04:34

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Medias…

ecancer

E. Zucca

196 views
06:28

Updates From the ECHELON-1 Trial Utilizing Brentuximab in Hodgkin’s …

PrecisCa

M. Kamdar

99 views
21:26

A+AVD in Frontline cHL: Barriers and Challenges

Hackensack Meridian John Theurer Cancer Center

T. Feldman

316 views
31:25

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Indy Hematology Review

M. Lunning

75 views
10:04

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

Stephen M. Ansell

679 views
15:23

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Clas…

EHA 2022 Conference Coverage

J. Radford

381 views
40:13

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

R. C. Lynch

425 views
27:15

Targeting and Treating Indolent Lymphomas and Hodgkin Lymphoma

Indy Hematology Review

N. Bartlett

74 views
41:20

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lymphoma

SOHO Highlights: State of the Art and Next Questions

N. Bartlett

349 views
19:27

Updates in Management of Hodgkin Lymphoma

Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

J. Svoboda

119 views